Merck Q4 net drops 14 pct. on generic competition
Merck & Co. reported a 14 percent decline in fourth-quarter profit as generic competition continued to cut into sales of one-time blockbuster medicines, and unfavorable currency exchange rates reduced overseas revenue.
Feb 5, 2014
0
0